cryptate

cryptate

[′krip‚tāt]
(inorganic chemistry)
The adduct formed between a cryptand and a guest (cation, anion, or neutral species) molecular entity.
References in periodicals archive ?
This assay is based on the competition between the sample free cortisol and XL665 labelled cortisol for binding to an anticortisol europium cryptate labelled antibody.
We measured the concentrations of PAPP-A and hCG[beta] by use of a homogeneous random-access semi-automated assay, employing time-resolved amplified cryptate emission (TRACE) technology using the Kryptor instrument (Brahms AG).
Anion receptor molecules: synthesis of an octaaza-cryptand and structure of its fluoride cryptate.
BRAHMS' KRYPTOR analysis systems can currently perform various analyses in random-access operations using TRACE (Time Resolved Amplified Cryptate Emission) technology, based on Forster resonance energy transfer (FRET).
Cisbio's cGMP assay kit is a homogeneous competitive immunoassay involving two HTRF congugates: cGMP coupled to XL665 and anti-cGMP monoclonal antibody labeled with Europium Cryptate.
We used time-resolved amplified cryptate emission (TRACE) technology in a Kryptor[R] autoanalyzer (BRAHMS) to measure plasma procalcitonin (PCT) concentrations in patients who developed an infection or AR on the day of the clinical diagnosis of these complications.
Further, with the development of its second generation HTRF technology, HTRF Terbium, Cisbio Bioassays has been able to improve assay performance over its previous generation HTRF, which was based on a Europium cryptate," notes Dr.
We set up a homogeneous sandwich fluoroimmunoassay using time-resolved amplified cryptate emission (TRACE) technology (29).
PCT concentrations were determined by the time-resolved amplified cryptate emission (TRACE) methodology on Kryptor (Brahms Diagnostic) by the same analyst, who followed the assay manufacturer's recommendations.
Time resolved amplification of cryptate emission: a versatile technology to trace biomolecular interactions [Review].
The 19-min homogeneous immunoassay technology (13), based on time-resolved amplified cryptate emission using chelates developed by Nobel Prize winner Jean-Marie Lehn, can be carried out in the same time that it takes a qualified sonographer to measure the fetal size (crown rump length) and nuchal translucency thickness and report a mini anomaly scan.